BNP Paribas’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
BNP Paribas's MRK Position: Q2 2026 in Review
BNP Paribas reduced its Merck (MRK) stake by 0.53% in Q2 2026, selling an estimated $46.7K and leaving 74,751 shares worth $9.59M. The position accounts for 0.26% of the portfolio, ranked #67.
BNP Paribas first reported a position in MRK in Q1 2024 and has held it in 10 quarters since. The position peaked at $40.9M in Q1 2024. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- BNP Paribas held 74,751 shares of Merck worth $9.59M as of Q2 2026.
- BNP Paribas sold 399 Merck shares in Q2 2026, an estimated $46.7K.
- Merck made up 0.26% of BNP Paribas's portfolio in Q2 2026, its #67 holding.
- BNP Paribas first reported a position in Merck in Q1 2024 and has held it in 10 quarters since.
- BNP Paribas's Merck position peaked at $40.9M in Q1 2024.
- 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on BNP Paribas's 13F filing for Q2 2026, filed 13 Aug 2026.